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Background/aim: DNA nanostructures have many advantages over polymers and lipid based drug delivery agents such as
biodegradability and biocompatibility. However their transfection rates and stability still limit their widely use in nanomedicine. In this
study highly versatile and straightforward albumin coating preparation method is showed for DNA nanostructures.
Materials and methods: N-methylolmaleimide was esterified with a-bromoisobutyrl bromide (BiBB) to achive bromine functional
structure. Then it was attached to bovine serum albumin (BSA) via cysteine-maleimide bond further to use as macroinitiator for atom
transfer radical polymerization (ATRP). Cationic polymers can be synthesized from this end further to use as binding domain for
fabricated 60 Helix bundle DNA origami.
Results: Proton nuclear magnetic resonance (1H NMR) analysis used for characterization. Methyelene group hydrogens’ peak in 5.0
ppm and strong peak in 1.5–2.0 ppm range showed proper methylolation of maleimide and bromine functional formation, respectively.
Then BSA-macroinitiator formation is verified by 1780 Da peak shift in MALDI-TOF (Matrix-assisted laser desorption/ionization time of flight) spectrum. Moreover electrophoretic mobility shift assay (EMSA) showed successful dense 60 Helix bundle formation.
Conclusion: In this study, a facile method is developed to synthesize protein conjugated-ATRP initiator further can be used in
polymerization and coating DNA nanostructures. It is feasible for any protein containing cysteine amino acid.
Keywords: DNA origami, bionanotechnology, atom transfer radical polymerization, drug delivery

1. Introduction
Structural DNA nanotechnology has made considerable
development since Seeman proposed using DNA as a
building material for bottom-up self-assembly in 1982 [1].
DNA origami is the common technique to form 2- and
3-dimensional nanostructures with exceptional complexity
in which a long single-stranded DNA is being folded by
hundreds of distinct complementary short ‘staple’ strands
[2–5]. It is employed in numerous applications such as
biosensors [6,7], advanced drug delivery [8], synthetic ion
channels [9], molecular size electronic circuits [10] and
plasmonic nanostructures [11].
In addition, these structures are highly suitable for
nanomedicine applications thanks to their size (10–
100nm). They are inherently biocompatible, nontoxic,
biodegradable, have low immunogenicity and can enter
cells without transfection agents [12–17]. Numerous
smart drugs carriers have developed so far to deliver
molecules include fluorescent dyes [18], anticancer drugs
[19, 20], CpG (unmethylated cytosine-phosphate-guanine
dinucleotides) [14], siRNA [21], enzymes [22]. Despite
these unique properties of DNA nanostructures, there are

still 2 key challenges to overcome the limiting factors of
their extensive usage. Firstly, due to negatively charged
hydrophilic nature of DNA origami it shows low celltransfection rates [23]. Secondly, these structures are often
sensitive to cellular medium and depletion of salt ions;
although they are slightly stable in cell lysates [24] and can
resist nuclease action [25], an efficient method to improve
their stability in vivo is urgently needed.
In order to increase the stability and transfection rates
of DNA nanostructures, various materials and protection
techniques suggested such as liposome encapsulation [26]
and polymer coating [27–31], backbone modification
[32], spermidine stabilization [33]. It has been shown
that transfection rates can be improved by utilizing DNA
intercalators as surface modification agents [34], virus
protein [35] and specific proteins studied so far [36].
However, taking into account the accessibility, selectivity
and immune responseserum albumin is an easily accessible
candidate for coating. Serum albumin is the most abundant
blood protein, and has long serum half-life and widely
used in clinically approved applications in drug delivery
[37,38]. The thiol-maleimide chemistry is frequently used
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for specific conjugation utilizing cysteine residue in serum
albumin [39–42]. Many techniques used to synthesize
polymers with protein reactive groups [43–45]. Grafting
from approach is the more recent method for synthesizing
polymeric biomaterials [46]. By creating specific sites on
biomacromolecules, living radical polymerization can be
initiated and broad range of protein-polymer conjugates
can be achieved. Consequently, by coating DNA
nanostructures with serum albumin, can these structures’
stability and transfection rates to the cells be increased?
In this study, BSA transformed into macroinitiator for
atom transfer radical polymerization (ATRP) by targeting
the free cysteine residue as reactive towards the maleimide.
This initiator can be used for having cationic polymer
and utilized as a binding domain that can be further
attached to the negatively charged DNA origami surface.
It is believed that this method will broaden applications of
DNA origami in nanomedicine as a novel alternative to the
nanoparticle and lipid based drug delivery carriers.
2. Materials and methods
In this study by coating DNA nanostructures with cationic
polymer armed albumin protein it is expected to increase
these structures’ stability and transfection rates to the
cells. The procedure is as follows: using maleimide as
a starting material and modifying it to have hydroxyl
group. Then from this functional group, a-bromoisobutyrl
bromide covalently bonded by esterification. After that
bromine functional maleimide conjugated with bovine
serum albumin (BSA) by cysteine-maleimide bond. Then
ATRP was performed from this macroinitiator by using
2-(dimethylamino) ethyl methacrylate (DMAEMA) as
monomer. 60 Helix bundle DNA origami prepared by
thermally annealing the scaffold by 141 distinct short
staple strands.
Maleimide supplied from Alfa Aesar [Thermo Fisher
(Kandel) GmbH, Kandel, Germany]. Formaldehyde,
α-bromoisobutyrl bromide (BiBB), bovine serum albumin,
2-(dimethylamino) ethyl methacrylate (DMAEMA)
monomer, ethidium bromide (EthBr) and agarose
were purchased from Sigma-Aldrich Chemie GmbH
(Taufkirchen, Germany). Milli-Q purified water was used.

Figure 1. Methylolation of maleimide.
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Scaffold for 60 Helix bundle DNA origami was purchased
from TilibitNanosystems (München, Germany) and
staple strands from Integrated DNA Technologies Inc.
(Coralville, IA, USA). 10x TAE buffer supplied from
USB Corporation (Cleveland, OH, USA). Proton nuclear
magnetic resonance (1H NMR) spectra were recorded with
Bruker Avance 400 MHz (Bruker BioSpin Corporation,
Billerica, MA, USA). The chemical shift calibration
performed using residual CDCl3 peaks. MALDI-TOF
analyses were performed with an UltrafleXtreme 2000 Hz
(Bruker Daltonics, Bremen, Germany) with a SmartBeam
II laser (355 nm) and operated in positive mode.
2.1. Synthesis of N-substituted maleimide derivative
N-methylolmaleimide was synthesized according to
the method Tawney et al. proposed (Figure 1) [47]. At
room temperature 90 mL of 5% sodium hydroxide was
added to a suspension of 2.910 g of maleimide in 5.559
g of 37% formaldehyde (final pH » 5). Within 10 min
all of maleimide was dissolved and a mildly exothermic
reaction occurred. Separation of the product was begun
promptly. After leaving for 2.5 h at room temperature,
the solution was filtered. One recrystallization from ethyl
acetate ended 1.12 g of product and it was dried under
vacuum to remove solvent.
Bromine functional maleimide was prepared
by esterification of N-methylolmaleimide with
a-bromoisobutyrl bromide according to the method
of Çakır et al. (Figure 2) [48]. Under nitrogen, 1.24 mL
(2.307 g, 10 mmol) a-bromoisobutyrl bromide was added
dropwise to a stirring mixture of NMM (1 g, 8 mmol) and
triethylamine (1.37 mL, 10 mmol) in 23.3 mL of CHCl3
in an ice bath for 1 h. After complete addition of the acid
bromide, the reaction was stirred at room temperature
for 3 h. A dark red reaction mixture observed and it was
washed with water (3 × 23.3 mL) and then dried over
MgSO4. After filtration and evaporation of CHCl3, it was
dried under vacuum and recrystallized from ethanol.
2.2. BSA-macroinitiator
Synthesis of BSA-macroinitiator targeted the free cysteine
residue (Cys-34) as reactive towards the maleimide,
described earlier by Nicolas et al. (Figure 3) [49]. BSA
(34 mg, 0.52 μmol) was dissolved in 4.6 mL of 100 mM
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phosphate buffer (pH = 7.0). A solution of 12.2 mg of
N-substituted maleimide derivative in 0.2 mL of DMSO
was added to this slowly. The mixture was gently stirred
during 24 h at ambient temperature and the solid residue
was then removed by centrifugation. The supernatant was
diluted with deionized water and dialyzed with a 12,000–
14,000 Da molecular weight cut-off (MWCO) membrane
against deionized water for 3 days. The solution was then
lyophilized to isolate the BSA-macroinitiator.
2.3. Atom transfer radical polymerization (ATRP)
BSA-polymer conjugate achieved via ATRP from BSA
macroinitiator, by using modified method of Välimäki
et al. (Figure 4) [50]. CuBr (53 mg, 0.37 mmol) was
placed in a round-bottom flask with a stirring bar. BSA
macroinitiator (25 mg, 0.37 mmol) and ligand HMTETA
(170 mg, 0.74 mmol) dissolved in 10 mL of water and
purged with nitrogen gas for 15 min. Then the solution
transferred to the flask by cannula. The same procedure
repeated for DMAEMA (5.8 g, 37 mmol) and the
polymerization was performed for 4 h in a sealed flask at

room temperature with magnetic stirring. For 240 min,
every 30 min sample was taken from the flask to vials,
then they were opened to air and placed in an ice bath
to stop the reaction. The solid residue was removed by
centrifugation, and the supernatant was lyophilized to
give blue product.
2.4. Preparation of DNA origami nanostructure
60 Helix bundle DNA origami nanostructure was
prepared, purified and characterized as described earlier
[51,52]. Briefly, folding solution obtained by mixing
following substances:
20 mL M13mp18 scaffold (100 nM)
40 mL staples (500 nM)
40 mL folding buffer containing 2.5 TAE, 12.5 mM
NaCl and 50 mM MgCl2
Then final solution was annealed by G-Storm
thermocycler (Gene Technologies Ltd., Melbourne,
Australia). The excess amount of staples was removed by
PEG-based purification. Folding and purification of DNA
origami is characterized by agarose gel electrophoresis.

Figure 2. Esterification of N-methylolmaleimide with BiBB.

Figure 3. Thioether bond formation between cysteine-maleimide derivative.

Figure 4. ATRP of BSA-polymer conjugate.
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3. Results and discussion
Similar results observed with the literature in the methylolation
of maleimide, maleimide quickly dissolved, and gave an
exothermic reaction [47]. Thin layer chromatography of
maleimide and methylolation step product confirmed the
proper methylolation of maleimide. Maleimide runs faster
than N-methylolmaleimide and was observed under UV
light (Figure 5).The structure of N-methylolmaleimide was
confirmed by 1H NMR recorded in CDCl3 as well. 1H NMR
spectrum displays signals corresponding to hydrogens of
methylene group and hydroxyl group thus proves the proper
methylolation of maleimide (Figure 6). 1H NMR (CDCl3), d
(ppm): 3.01–3.05 (t, 1H), 5.00–5.04 (d, 2H), 6.70–6.72 (s, 2H).
To validate the structure of bromine functional maleimide
(MBr), 1H NMR spectrum recorded in CDCl3. The resonance
signals and relative intensities corresponding to methylene
(-CH2) and methyl (-CH3) groups evidenced successful
esterification, denoted in b and c respectively and it is found
compatible with the results reported earlier (Figure 7) [48].
1H NMR (CDCl3), d (ppm): 1.82–1.85 (s, 6H), 5.56–5.57 (s,
2H), 6.77–6.78 (s, 2H). Conjugation of bromine functional
maleimide (MBr) to BSA was demonstrated by MALDI-TOF.
Incubation of BSA with MBr showed a shift to position 68413
m/z (Figures 8A and 8B). This corresponds to a change of
1780 Da and proves proper conjugation of bromine functional
maleimide (MBr) to BSA (Figure 8). Polymerization from
BSA macroinitiator was followed by 1H NMR. In order to be
ensure the complete dissolution of the sample, 0.7 mL CDCl3
mixed with 0.3 mL CD3OD and used as solvent. The resonance
signal corresponding to repeating unit (methylene) group of
PDMAEMA was searched around 1.0 ppm, however no peak
observed in after 30 min (Figure 9A), 240 min. (Figure 9B),

240 min and dilution with water 1:1 volumetric ratio (Figure
9C). This can be attributed to side reaction between functional
groups on amino acid residues and DMAEMA monomer.
Moreover, the mechanism can be slow due to the big structure
of BSA, and 240 min is not enough to observe the polymer
peak on 1H NMR spectrum. To overcome this issue, different
polymerization medium and ratios of the substances will be
tried. Gel electrophoretic mobility shift assay (EMSA) verified
that folded and compact 60HB runs faster than the scaffold as
shown in (Figure 10). Besides, PEG purification step removed
the excess staples efficiently. However there may be some
possible limitations in the study such asin MALDI-TOF
analysis chemical shift between BSA and BSA macroinitiator
comparison, it is unclear the ratio of one to one chemical
conjugates to the electrostatically gathered structures.
4. Conclusion
As a conclusion, we demonstrated a facile and widely
applicable method to prepare BSA macroinitiator that can
be further used in preparation of polymeric biomaterials.
Characterization stages have given valuable information
about transformation of maleimide to bromine functional
initiator and thioether formation by Michael addition of
maleimide end to thiol of cysteine residues. Though the weak
polymer peak for backbone in 1H NMR spectrum, a clear shift
in MALDI-TOF spectra has provided an evidence for proteininitiator binding. In this method, any cysteine containing
proteins can be selectively conjugated with bromine
functional ATRP initiator, however polymerization medium
should be taken into account to avoid denaturation of protein.
Therefore, this approach offers notable opportunities which
can be extended not only for DNA origami coating but also
for responsive biohybrid material development. This method
makes considerable contribution for attracting the attention
to DNA origami studies and to future studies with BSA-like
biocompatible proteins and polymers.
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Figure 6. 1H NMR spectrum of N-methylolmaleimide.

Figure 7. 1H NMR spectrum of bromine functional maleimide (MBr).
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Figure 8. MALDI-TOF spectra of A) BSA and B) BSA macroinitiator.

Figure 9. Resonance signals of according to chemical shifts shown in ppm in NMR spectra of samples taken from polymerization
medium after A) 30 min, B) 240 min C) 240 min and dilution with water 1:1 volumetric ratio.
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Figure 10. Electrophoretic mobility shift assay (EMSA) results for folded and purified
60HB DNA origami.
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